SIGA’s Tecovirimat approved in UK to treat complications after smallpox vaccination
The UK health regulator indicated Tecovirimat for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications, after vaccination…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Jul 22
The UK health regulator indicated Tecovirimat for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications, after vaccination…
11 Jul 22
As per the agreement, the companies will develop and market Zynlonta for all hematologic and solid tumour indications,…
08 Jul 22
Emergent will manufacture, sell, and distribute Ebanga in the US and Canada, while Ridgeback will serve as the…
08 Jul 22
With the acquisition of Seagen, Merck is enabled to widen its cancer drugs portfolio, which is currently led…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Jul 22
The British drugmaker will acquire all the outstanding equity in TeneoTwo, along with its clinical-stage cancer therapy candidate…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Jul 22
The company’s claim was based on more than two decades of work on mRNA technology, which played a…
05 Jul 22
WuXi Biologics said the expansion is in response to growing market demand and will enable it to provide…
04 Jul 22
Under the new agreement, Oxford Biomedica will manufacture AstraZeneca’s Covid-19 vaccines at its 84,000ft² manufacturing facility in Oxbox,…
04 Jul 22
The company is entitled to receive a settlement fee of $55m and will assume responsibility for the marketing…
01 Jul 22
The financing from two life science-focused investors is expected to provide capital to expand Blueprint’s pipeline towards commercialisation…